Quality of life associated with diabetes mellitus in an adult population

被引:140
作者
Brown, GC [1 ]
Brown, MM [1 ]
Sharma, S [1 ]
Brown, H [1 ]
Gozum, M [1 ]
Denton, P [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Wills Eye Hosp, Retina Vasc Unit, Philadelphia, PA 19107 USA
关键词
diabetes mellitus; utility analysis; quality of life;
D O I
10.1016/S1056-8727(00)00061-1
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
To ascertain the quality of life associated with the health state of diabetes mellitus using utility value analysis. Consecutive adult patients with diabetes mellitus for at least 1 year and a mean age of 61.7 years (range 21-85 years) were interviewed in a cross-sectional fashion using standardized research methodology. Utility analysis values were obtained employing the time tradeoff method and were correlated with clinical parameters of the sample group, as well as with co-morbidities using the heteroscedastic Student's t-test and multivariate linear regression. The chi(2) distribution to test for independence was used to compare sample subgroups. With a sample of 292 patients, the mean, patient-preference-based, time tradeoff utility value associated with the health state of diabetes mellitus was 0.88 (standard deviation (SD) = 0.17; 95% confidence interval (CT), 0.86-0.90). Repeat analysis confirmed the reproducibility of the data. Thus, the average diabetic was willing to trade away 12% of his or her remaining life in return for a diabetic-free health state. Factors associated with a significant decrease in diabetic-associated quality of life included: ii) the requirement for insulin (p = 0.05), (2) the presence of depression (p = 0.01), (3) the presence of diabetic retinopathy (p = 0.03) and the presence of co-morbidities in general (p = 0.01). The health state of diabetes mellitus has a significant effect upon patient, preference-based quality of life. The presence of diabetic co-morbidities and dependence upon insulin appear to decrease quality of life. The utility value associated with the health state of diabetes mellitus is of substantial importance for use in the calculation of cost-effective analyses. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 26 条
[2]
BEERS MH, 1999, MERCK MANUAL, P15
[3]
BENSON WE, 1988, DIABETES ITS OCULAR, P1
[4]
Cost-effectiveness of treatment for threshold retinopathy of prematurity [J].
Brown, GC ;
Brown, MM ;
Sharma, S ;
Tasman, W ;
Brown, HC .
PEDIATRICS, 1999, 104 (04) :e47
[5]
BROWN GC, 1999, T AM OPHTHAL SOC, V92, P474
[6]
BROWN GC, 1999, CURR OPIN OPHTHALMOL, V10, P221
[7]
Utility values and diabetic retinopathy [J].
Brown, MM ;
Brown, GC ;
Sharma, S ;
Shah, G .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (03) :324-330
[8]
BROWN MM, 1999, J HEALTHCARE FIN, V26, P14
[9]
BROWN MM, 1999, EVIDENCE BASED EYE C, V1, P54
[10]
Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195